These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors. Bomanji J, Mather S, Moyes J, Ellison D, Grossman A, Britton KE, Besser GM. J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726 [Abstract] [Full Text] [Related]
3. Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide. Isidori AM, Kaltsas G, Frajese V, Kola B, Whitelocke RA, Plowman PN, Britton KE, Monson JP, Grossman AB, Besser GM. J Clin Endocrinol Metab; 2002 Apr; 87(4):1627-33. PubMed ID: 11932293 [Abstract] [Full Text] [Related]
4. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue. Macfarlane D, Gonin J, Wieland D, Mangner T, Froelich J, Beierwaltes W, Shapiro B. Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846 [Abstract] [Full Text] [Related]
5. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids]. Bihl H, Sautter-Bihl ML, Wilhelm KR, Kimmig B. Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170 [Abstract] [Full Text] [Related]
8. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors. Bongers V, de Klerk JM, Zonnenberg BA, de Kort G, Lips CJ, van Rijk PP. J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784 [Abstract] [Full Text] [Related]
10. [131I]metaiodobenzylguanidine therapy in carcinoid tumors. Castellani MR, Di Bartolomeo M, Maffioli L, Zilembo N, Gasparini M, Buraggi GL. J Nucl Biol Med (1991); 1991 Jul; 35(4):349-51. PubMed ID: 1823855 [Abstract] [Full Text] [Related]
11. Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine. Hoefnagel CA, Den Hartog Jager FC, Van Gennip AH, Marcuse HR, Taal BG. Clin Nucl Med; 1986 Mar; 11(3):150-2. PubMed ID: 3956021 [Abstract] [Full Text] [Related]
12. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours. Taal BG, Hoefnagel CA, Valdés Olmos RA, Boot H. Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676 [Abstract] [Full Text] [Related]
13. Carcinoid tumor metastases to the extraocular muscles: MR imaging and CT findings and review of the literature. Gupta A, Chazen JL, Phillips CD. AJNR Am J Neuroradiol; 2011 Aug; 32(7):1208-11. PubMed ID: 21659479 [Abstract] [Full Text] [Related]
14. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients. Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman J, Onaitis MW, Tyler DS, Olson JA. Cancer; 2004 Nov 01; 101(9):1987-93. PubMed ID: 15455358 [Abstract] [Full Text] [Related]
15. MR imaging of a carcinoid tumor metastatic to the orbit. Braffman BH, Bilaniuk LT, Eagle RC, Savino PJ, Hackney DB, Grossman RI, Goldberg HI, Zimmerman RA. J Comput Assist Tomogr; 1987 Nov 01; 11(5):891-4. PubMed ID: 3655056 [Abstract] [Full Text] [Related]
17. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors. Taal BG, Hoefnagel CA, Valdes Olmos RA, Boot H, Beijnen JH. J Clin Oncol; 1996 Jun 01; 14(6):1829-38. PubMed ID: 8656251 [Abstract] [Full Text] [Related]
18. [Clinical relevance of I-123/I-131-MIBG scintigraphy in intestinal carcinoid tumors]. van de Flierdt E, Frank T, Laubenbacher C, Fink U, Bauer R, Langhammer HR, Pabst HW. Nuklearmedizin; 1998 Jun 01; 37(4):129-33. PubMed ID: 9650212 [Abstract] [Full Text] [Related]